Literature DB >> 2828687

Unusual DNA structure in the regulatory region of the human papovavirus JC virus.

S Amirhaeri1, F Wohlrab, E O Major, R D Wells.   

Abstract

The human papovavirus JC virus (JCV) was analyzed for the presence of unusual DNA conformations. Recombinant plasmids containing 60% of the JCV prototype Mad-1 strain DNA were constructed and analyzed with both enzymatic and chemical probes. Fine-mapping studies revealed that the most prominent S1 nuclease-sensitive and bromoacetaldehyde-modified sites were located within the TATA boxes of each 98-base-pair tandem repeat. Further studies revealed that the S1 nuclease-sensitive site in the first TATA box (proximal to the origin) was approximately 50-fold stronger than the site in the second TATA box (distal from the origin). Deletion of the first TATA box drastically reduced the extent of bromoacetaldehyde modification in the second TATA box, whereas deletion of the second TATA box had little or no effect on the reactivity at the first TATA box. Hence, the biological and conformational role of the second TATA box remains unclear. No supercoil-induced relaxation was found, and reactions with the probes were not pH dependent. Also, fragments containing this regulatory region did not appear to be bent, although the A+T-rich segment contained a tract of eight consecutive A's. We conclude that the regulatory region of JCV contains non-B, but right-handed, DNA conformations which account for this behavior.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828687      PMCID: PMC253651          DOI: 10.1128/JVI.62.3.922-931.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  The genome of simian virus 40.

Authors:  V B Reddy; B Thimmappaya; R Dhar; K N Subramanian; B S Zain; J Pan; P K Ghosh; M L Celma; S M Weissman
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

2.  Complete nucleotide sequence of SV40 DNA.

Authors:  W Fiers; R Contreras; G Haegemann; R Rogiers; A Van de Voorde; H Van Heuverswyn; J Van Herreweghe; G Volckaert; M Ysebaert
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

3.  Binding of anti-Z-DNA antibodies to negatively supercoiled SV40 DNA.

Authors:  A Nordheim; R E Herrera; A Rich
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

4.  Physical characterization of a kinetoplast DNA fragment with unusual properties.

Authors:  J C Marini; P N Effron; T C Goodman; C K Singleton; R D Wells; R M Wartell; P T Englund
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

5.  S1 sensitive sites in adenovirus DNA.

Authors:  C R Goding; W C Russell
Journal:  Nucleic Acids Res       Date:  1983-01-11       Impact factor: 16.971

6.  Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus.

Authors:  L A Laimins; P Gruss; R Pozzatti; G Khoury
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

7.  The early region of human papovavirus JC induces dysmyelination in transgenic mice.

Authors:  J A Small; G A Scangos; L Cork; G Jay; G Khoury
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

8.  Human papovavirus (JC): induction of brain tumors in hamsters.

Authors:  D L Walker; B L Padgett; G M ZuRhein; A E Albert; R F Marsh
Journal:  Science       Date:  1973-08-17       Impact factor: 47.728

9.  Experimental glioma in primates: a computed tomography model.

Authors:  K G Rieth; G Di Chiro; W T London; J L Sever; S A Houff; P L Kornblith; P E McKeever; C Buonomo; B L Padgett; D L Walker
Journal:  J Comput Assist Tomogr       Date:  1980-06       Impact factor: 1.826

10.  Effects of salts, temperature, and stem length on supercoil-induced formation of cruciforms.

Authors:  C K Singleton
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

View more
  7 in total

1.  Sp1 sites in the noncoding control region of BK polyomavirus are key regulators of bidirectional viral early and late gene expression.

Authors:  Tobias Bethge; Helen A Hachemi; Julia Manzetti; Rainer Gosert; Walter Schaffner; Hans H Hirsch
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

Review 2.  Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Authors:  Amir Khalili; Michael Craigie; Martina Donadoni; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

3.  Identification of critical elements within the JC virus DNA replication origin.

Authors:  K J Lynch; R J Frisque
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

Review 4.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

5.  A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus.

Authors:  H Tada; K Khalili
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

Review 6.  Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  E O Major; K Amemiya; C S Tornatore; S A Houff; J R Berger
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

7.  Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element.

Authors:  N N Chen; C F Chang; G L Gallia; D A Kerr; E M Johnson; C P Krachmarov; S M Barr; R J Frisque; B Bollag; K Khalili
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.